Form 4: GoodRx Director Scott Wagner Reports Acquisition of Class A Common Stock and Deferred Stock Units
SEC Form 4
Director Scott Wagner reports the acquisition of Class A Common Stock and Deferred Stock Units in GoodRx Holdings, Inc.
Summary
- On January 21, 2025, Scott Wagner, a director of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock and Deferred Stock Units.
- Wagner acquired 9,524 shares of Class A Common Stock and 19,217 shares of Class A Common Stock, both at a price of $0.
- Following these transactions, Wagner directly owns 317,850 shares of Class A Common Stock.
- Wagner also indirectly owns 182,900 shares of Class A Common Stock through the Wagner Family Trust.
- Additionally, Wagner acquired 94,182 Deferred Stock Units, each representing a contingent right to receive one share of Class A Common Stock.
- These deferred stock units vest in one-third increments on each of the first three anniversaries of the grant date, starting January 21, 2026, subject to continued service.
- The deferred stock units will settle on the earliest of December 31, 2030, separation from service, a change in control, death, or disability.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing detailing stock transactions by a company director. The acquisition of shares and deferred stock units can be seen as a positive sign of confidence, but it's also part of standard compensation practices.
Positives
- The acquisition of shares by a director could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The deferred stock units vest over time, subject to continued service, and will settle upon specific events, indicating a long-term commitment from the director.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder sentiment, as they reflect insider confidence.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of earliest transaction: Acquisition of Class A Common Stock and Deferred Stock Units. |
| 01/23/2025 | Date of signature by Attorney-in-Fact. |
| 01/31/2025 | First monthly installment vesting date for some deferred stock units. |
| 06/06/2025 | Potential vesting date for some deferred stock units. |
| 01/21/2026 | First anniversary of grant date for deferred stock units, with one-third of shares vesting. |
| 12/31/2030 | Latest possible settlement date for deferred stock units. |
Keywords
GoodRx, Wagner, Director, Class A Common Stock, Deferred Stock Units, Beneficial Ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.